Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-14

Clinical Trial Update: Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective Psychosis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing aripiprazole, quetiapine, and ziprasidone in first-episode nonaffective psychosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abilify (aripiprazole)
  • Geodon (Ziprasidone)
  • SEROQUEL (QUETIAPINE)

Snippet

Sponsor: Fundación Marques de Valdecilla | Conditions: Schizophrenia, Psychotic Disorders | Phase 4 | Status: COMPLETED